News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Alert>GENSCRIPT BIO Expects Interim Turnaround w/ PBT as High as US$200M
GENSCRIPT BIO (01548.HK) issued a positive profit alert expecting to record a turnaround for the six months ended 30 June 2025, with profit before tax of US$175.4 million to US$204...
Reset
Send
The window will close in 5 seconds
<Alert>GENSCRIPT BIO Expects Interim Turnaround w/ PBT as High as US$200M
Close
Recommend
7
Positive
10
Negative
4
 
SHORT SELL
 
STOCK INFO

GENSCRIPT BIO (01548.HK)  -0.300 (-1.638%)    Short selling $42.59M; Ratio 7.003%   issued a positive profit alert expecting to record a turnaround for the six months ended 30 June 2025, with profit before tax of US$175.4 million to US$204.6 million, compared to a loss before tax of approximately US$127.9 million in the same period of 2024.

Dividend History
Announce DateEventParticular
2025/03/12FinalNo Dividend
2024/08/09InterimNo Dividend
2024/03/10FinalNo Dividend
2023/08/20InterimNo Dividend

The company explained that the improvement in results is mainly due to a significant increase in licensing revenue to no less than US$182.2 million to US$212.5 million, mainly caused by the sublicense revenue generated from LaNova Medicines and the decrease of the non-cash fair value loss derived from preferred shares of Probio Technology.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-24 16:25.)

Related NewsGuotai Haitong Lists Changes in Mkt Value of Shrs Held by CN Public Funds in HK Stocks by Sector in 2Q (Table)
AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.